Investment
Features
FeesSafety
Academy
More
Pluang+

Cohen & Steers launches CSRA ETF for diversified real assets exposure including real estate and commodities.

Others
12 Aug 2026
PRNewsWire
View Source
Bullish
pluang ai news

Cohen & Steers has introduced the Cohen & Steers Real Assets Active ETF (CSRA), an actively managed fund that invests across real estate, infrastructure, natural resources, and commodities. This ETF aims to provide investors with inflation sensitivity, diversification, and long-term return potential amid rising demand and supply constraints in energy and materials. CSRA began trading on the NYSE Arca, expanding Cohen & Steers' lineup of active ETFs designed to offer diversified access to essential global economic assets. The launch reflects growing investor interest in active ETFs and real asset strategies as a hedge against inflation and market volatility.

More News

BP shifts assets and invests in Brazil amid mixed analyst ratings.

BP shifts assets and invests in Brazil amid mixed analyst ratings.

BP, a major global energy company, is actively managing its portfolio by potentially selling oil and gas assets in Egypt to Energean and investing in new projects like a Halliburton contract in Brazil's offshore field. This strategic move aims to enh...

Market News
Neutral
20 minutes ago
Pernod Ricard beats Q4 2026 earnings estimates despite sales declines in US and China.

Pernod Ricard beats Q4 2026 earnings estimates despite sales declines in US and China.

Pernod Ricard reported Q4 2026 earnings per share of $0.42 and revenue of $4.90 billion, both surpassing analyst expectations. However, the company faces significant organic sales declines of 14% in the US and 19% in China due to weak consumer demand...

Company Fundamentals
Neutral
1 hour ago
BYD set for strong Q2 earnings with rising EV sales and global expansion boosting profits.

BYD set for strong Q2 earnings with rising EV sales and global expansion boosting profits.

BYD Company Limited is expected to report strong Q2 earnings driven by robust electric vehicle sales and growing exports. The company surpasses Tesla in gross profit margins and delivery volume, highlighting its competitive edge. BYD's strategic focu...

Company Fundamentals
Bullish
1 hour ago
Diodes Inc. stock up 19% in 30 days despite recent 12% dip, with strong analyst target of $192.

Diodes Inc. stock up 19% in 30 days despite recent 12% dip, with strong analyst target of $192.

Diodes Incorporated's stock surged 19.27% over the past 30 days, showing strong market momentum despite a recent 12.30% pullback in the last 10 days. This decline has brought the stock to a local low, potentially attracting investors looking for entr...

Analyst Insights
Bullish
1 hour ago
Alterity Therapeutics advances neurological drugs with stable $8.67 price target, some optimism at $12.

Alterity Therapeutics advances neurological drugs with stable $8.67 price target, some optimism at $12.

Alterity Therapeutics Limited is developing experimental drugs ATH434 and PBT2 targeting Parkinson's and Alzheimer's diseases. The consensus analyst price target remains steady at $8.67, reflecting consistent market confidence, while some analysts li...

Analyst Insights
Neutral
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App